Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert P Byington

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Current Atherosclerosis Reports|August 7, 2004
Lessons learned from the prospective pravastatin pooling projectRobert P Byington, Frank M Sacks
Diabetes Care|March 1, 2005
The burden of treatment failure in type 2 diabetes: response to Brown et alDenise G Simons-Morton, Saul Genuth, Robert P Byington, et al.
Obstetrics and Gynecology|August 9, 2003
Pregnancy-related death and health care servicesMargaret A Harper, Robert P Byington, Mark A Espeland, et al.
Hypertension (Dallas, Tex. : 1979)|October 14, 2015
Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Diabetes Mellitus: Action to Control Cardiovascular Risk in Diabetes Blood Pressure TrialElsayed Z Soliman, Robert P Byington, J Thomas Bigger, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 26, 2014
Fibroblast growth factor 23 and incident CKD in type 2 diabetesTamara Isakova, Timothy E Craven, Jungwha Lee, et al.
Circulation|May 22, 2002
Safety and tolerability of pravastatin in long-term clinical trials: prospective Pravastatin Pooling (PPP) ProjectMarc A Pfeffer, Anthony Keech, Frank M Sacks, et al.
Diabetes Care|October 31, 2013
Effects of randomization to intensive glucose control on adverse events, cardiovascular disease, and mortality in older versus younger adults in the ACCORD TrialMichael E Miller, Jeff D Williamson, Hertzel C Gerstein, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 16, 2002
Effect of estrogen plus progestin on progression of carotid atherosclerosis in postmenopausal women with heart disease: HERS B-mode substudyRobert P Byington, Curt D Furberg, David M Herrington, et al.
The American Journal of Cardiology|July 12, 2007
Prevention of cardiovascular disease in persons with type 2 diabetes mellitus: current knowledge and rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trialDavid C Goff, Hertzel C Gerstein, Henry N Ginsberg, et al.
Diabetes Care|April 30, 2010
Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trialMatthew C Riddle, Walter T Ambrosius, David J Brillon, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Current Atherosclerosis Reports|August 7, 2004
Lessons learned from the prospective pravastatin pooling projectRobert P Byington, Frank M Sacks
Diabetes Care|March 1, 2005
The burden of treatment failure in type 2 diabetes: response to Brown et alDenise G Simons-Morton, Saul Genuth, Robert P Byington, et al.
Obstetrics and Gynecology|August 9, 2003
Pregnancy-related death and health care servicesMargaret A Harper, Robert P Byington, Mark A Espeland, et al.
Hypertension (Dallas, Tex. : 1979)|October 14, 2015
Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Diabetes Mellitus: Action to Control Cardiovascular Risk in Diabetes Blood Pressure TrialElsayed Z Soliman, Robert P Byington, J Thomas Bigger, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 26, 2014
Fibroblast growth factor 23 and incident CKD in type 2 diabetesTamara Isakova, Timothy E Craven, Jungwha Lee, et al.
Circulation|May 22, 2002
Safety and tolerability of pravastatin in long-term clinical trials: prospective Pravastatin Pooling (PPP) ProjectMarc A Pfeffer, Anthony Keech, Frank M Sacks, et al.
Diabetes Care|October 31, 2013
Effects of randomization to intensive glucose control on adverse events, cardiovascular disease, and mortality in older versus younger adults in the ACCORD TrialMichael E Miller, Jeff D Williamson, Hertzel C Gerstein, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 16, 2002
Effect of estrogen plus progestin on progression of carotid atherosclerosis in postmenopausal women with heart disease: HERS B-mode substudyRobert P Byington, Curt D Furberg, David M Herrington, et al.
The American Journal of Cardiology|July 12, 2007
Prevention of cardiovascular disease in persons with type 2 diabetes mellitus: current knowledge and rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trialDavid C Goff, Hertzel C Gerstein, Henry N Ginsberg, et al.
Diabetes Care|April 30, 2010
Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trialMatthew C Riddle, Walter T Ambrosius, David J Brillon, et al.
Pageof 2